Stock Market News

21 hours AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

AbbVie has a lofty goal for 2025 — and a big move in cancer treatment could stoke beleaguered AbbVie stock.
The post AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? appeared first on Investor's Business D…

AbbVie (ABBV) · Pfizer (PFE)

10 hours Final Trade: GOOG, SAIA, X, PFE YouTube

11 hours Pfizer climbs 4% on 2025 outlook YouTube

16 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

17 hours Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

18 hours Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

19 hours Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

20 hours Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

20 hours Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

21 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

21 hours Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com

21 hours Pfizer forecasts in line 2025 profit as it seeks turnaround Investing.com

21 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views Yahoo Finance

21 hours Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Yahoo Finance

22 hours Pfizer projects 2025 earnings to align with expectations Investing.com

22 hours Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC

22 hours Pfizer forecasts 2025 profit in line with expectations Investing.com

23 hours These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More Yahoo Finance

24 hours Stocks to Watch Tuesday: Pfizer, Alibaba, Super Micro, Affirm Yahoo Finance

1 day AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks

2 days AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha

2 days What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Yahoo Finance

2 days ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

2 days ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

2 days Pfizer: Lowest Levels In A Decade Is An Opportunity With A Dividend Yield Exceeding 6.5% Seeking Alpha

3 days Pfizer: Irrational Anti-Vaccine Fear Seeking Alpha

3 days Is Pfizer a Millionaire Maker? Yahoo Finance

6 days How Pfizer management outplayed activist investor Starboard Yahoo Finance

6 days Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

6 days Pfizer: Peer-Leading Dividend And Potential Substantial Shareholder Returns Seeking Alpha

7 days Amazon, Pfizer execs seek common ground with RFK Jr on climate risks to health Investing.com

7 days Betting Big On AbbVie: A Prescription For Growth And Dividends Seeking Alpha

1 week Pfizer Stock: A Golden Buying Opportunity (Rating Upgrade) Seeking Alpha

1 week AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks

1 week The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

1 week Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

1 week AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025 MarketWatch

1 week AbbVie reports positive results in Parkinson’s trial Investing.com

2 weeks Zacks.com featured highlights Urban Outfitters, Maplebear, Pfizer and Alcoa Zacks

2 weeks Calls of the Day: Toast, Abbvie, Berkshire Hathaway YouTube

2 weeks Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports Investing.com

2 weeks Pfizer: Too Cheap To Ignore Seeking Alpha

2 weeks Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks

2 weeks Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? Yahoo Finance

2 weeks AbbVie Inc. (ABBV) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

2 weeks Pfizer’s New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments Yahoo Finance

2 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

2 weeks Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform Yahoo Finance

2 weeks Zacks.com featured highlights Tyson Foods, AXIS Capital, Pfizer and General Motors Zacks

2 weeks Mastercard, Broadcom, Pfizer Among Two Dozen Companies To Announce Dividend Increases In December Seeking Alpha

3 weeks Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report? Zacks

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.